A Phase 3, Open-label Study Evaluating the Long term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older
Year: 2024
Date: new
Author:
Participants
patients with
Interventions
0
Outcome measures
0
Keywords: BI 3720931; Gene Transfer Techniques; non pharmacological intervention - genetic& reprod;